Showing posts with label
BEAM Therapeutics
.
Show all posts
Showing posts with label
BEAM Therapeutics
.
Show all posts
Thursday, September 25, 2025
Today, I revisited BEAM Therapeutics and noted institutional investors increasing their positions! Here's the lowdown!
›
Quite a few funds besides Peregrine (17% this month) boosted their positions in BEAM Therapeutics in the last ~3 months. The biggest disc...
Tuesday, July 15, 2025
An updated report (as of July 15 2025) on Beam Therapeutics (NASDAQ: BEAM):
›
🔬 1. Technology Advances & Pipeline Base editing leadership : Beam continues refining its precision base editing platform, enabl...
Monday, June 16, 2025
How BEAM Therapeutics Base editing technology and patents are validated by the treatment of Baby KJ
›
A groundbreaking treatment that saved baby KJ earlier in 2025 used base editing —a precise form of gene editing—developed through the par...
›
Home
View web version
